| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |